Status:
RECRUITING
Cognitive Remediation Intervention to Prepare for Transition of Care
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Sickle Cell Disease
Cognitive Impairment
Eligibility:
All Genders
10-18 years
Phase:
PHASE2
Brief Summary
Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention to prepare adolescents...
Detailed Description
Cognitive impairment is a pervasive debilitating feature of sickle cell disease (SCD), with over 50% of children demonstrating early neurodevelopmental delays, ultimately influencing ability for adole...
Eligibility Criteria
Inclusion
- Diagnosis of SCD (all genotypes)
- Active follow-up at Children's of Alabama Hospital
- Ages 10-18
- English-speaking
Exclusion
- History of seizures or overt stroke
- History of Intellectual Disability or Autism Spectrum Disorder
- Inability to participate in the MRI scan, such as metal implants, neurostimulators, claustrophobia
- Currently on psychotropic medications
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05336201
Start Date
July 1 2022
End Date
June 30 2027
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233